KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $33,342,000 | +3512.4% | 185,421 | +1983.9% | 0.03% | +3000.0% |
| Q2 2017 | $923,000 | +54.6% | 8,898 | +17.0% | 0.00% | 0.0% |
| Q1 2017 | $597,000 | +26.5% | 7,605 | -17.9% | 0.00% | – |
| Q4 2016 | $472,000 | +31.8% | 9,262 | +44.6% | 0.00% | – |
| Q3 2016 | $358,000 | +11.9% | 6,405 | 0.0% | 0.00% | – |
| Q2 2016 | $320,000 | +2185.7% | 6,405 | +2056.6% | 0.00% | – |
| Q1 2016 | $14,000 | -22.2% | 297 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | -82.0% | 297 | -83.5% | 0.00% | – |
| Q3 2015 | $100,000 | -92.8% | 1,797 | -92.1% | 0.00% | -100.0% |
| Q2 2015 | $1,389,000 | +2.6% | 22,781 | -2.9% | 0.00% | 0.0% |
| Q1 2015 | $1,354,000 | +515.5% | 23,453 | +514.8% | 0.00% | – |
| Q4 2014 | $220,000 | +165.1% | 3,815 | +30.6% | 0.00% | – |
| Q3 2014 | $83,000 | – | 2,921 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $108,260,000 | 37.66% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,479,000 | 8.02% |
| RTW INVESTMENTS, LP | 343,503 | $15,770,000 | 5.72% |
| DSAM Partners (London) Ltd | 256,550 | $11,778,000 | 5.26% |
| Silver Rock Financial LLC | 109,199 | $5,013,000 | 5.09% |
| Casdin Capital, LLC | 75,000 | $3,443,000 | 3.95% |
| EcoR1 Capital, LLC | 150,000 | $6,887,000 | 2.41% |
| Vivo Capital, LLC | 193,193 | $8,869,000 | 2.22% |
| BB BIOTECH AG | 750,000 | $34,433,000 | 1.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 494,988 | $22,725,000 | 1.36% |